Dyne Therapeutics
Dyne Therapeutics is advancing life-transforming therapeutics for people living with genetically driven, neuromuscular diseases. Our pioneering approach Utilizing our FORCE™ platform to …
Investors & Media | Dyne Therapeutics, Inc.
Mar 20, 2025 · Leveraging the modularity of its FORCE™ platform, Dyne is developing targeted therapeutics to deliver therapies to muscle and the central nervous system (CNS). Dyne has a …
Pipeline - Dyne Therapeutics
DYNE-101 is an investigational therapeutic being evaluated in the Phase 1/2 global ACHIEVE clinical trial for people living with DM1. DYNE-101 consists of an antisense oligonucleotide …
About Us - Dyne Therapeutics
We have assembled an exceptional team with deep experience in neuromuscular disease, rare disorders, drug development, and manufacturing and commercialization of novel therapeutics. …
Careers + Culture - Dyne Therapeutics
Dyne is an opportunity to take cutting-edge nucleic acid-based therapeutics and use our understanding of human biology to overcome the next set of hurdles in precision medicine. …
Dyne Therapeutics Announces New Clinical Data from ACHIEVE …
May 20, 2024 · With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle …
Dyne Therapeutics Announces New Clinical Data from Phase 1/2 …
Sep 3, 2024 · With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a …
Press Releases | Dyne Therapeutics, Inc.
Feb 14, 2025 · Dyne Therapeutics Reports New Clinical Data Showing Compelling Impact on Multiple Measures of Myotonic Dystrophy Type 1 (DM1); Dyne Plans to Initiate Registrational …
Clinical Trials - Dyne Therapeutics
Dyne Therapeutics is discovering and advancing potentially life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Clinical trials, a type of research …
Our FORCE<sup>TM</sup> Platform - Dyne Therapeutics
The FORCE TM platform drives Dyne’s efforts to develop targeted therapeutics for muscle and the central nervous system (CNS) delivery, to stop or reverse disease progression. It …